Saroll down
An innovative biopharmaceutical company
Aims to bring cellular new drug into new geographics
An innovative biopharmaceutical company
A core team with global vision and expertise
In whole industrial operation
A core team with global vision and expertise
An integrated Mix of diverse pipelines
An innovative biopharmaceutical company
A core team with global vision and expertise
01
About Us
About Us

Shenzhen Pregene Biopharma Co., Ltd. (874090), a national high-tech enterprise with the mission of “Developing urgently needed cell and gene therapy drugs for clinical treatment”, is one of the founders of Guangdong Research Center for Innovative Drug Engineering Technology of Cell and Gene Therapy, and one of Shenzhen Specialized and Sophisticated Enterprises. It has been deeply involved in the field of cell and gene therapy drugs for many years.

Glorious History (since year)
2012
Area (square meter)
10000
R&D (staff)
80+
Project (pcs)
20+
Cell and gene drug technology Platform

Cellular Drug R&D
and Industrialization Platform

Multi-gene editing platform

IPSC Reprogramming and
Multi-gene Editing Platform

cell-directed differentiation platforms

Multiple Cell-directed
Differentiation Platforms

03
three
Nano antibody

Nanobody
Screening Platform

04
four
induced Pluripotent Stem Cells

IPSCs Reprogramming
and Multi-gene Editing Platform

05
five
Pipeline
Pipelines
Advantages of Pregene's
CAR-T/CAR-NK

Diverse Process, Flexible Roadmap

Equipped with disposable automatic/semi-automatic closed systems for cell culture, isolation and separation.

Recruit
Recruitment

Recruitment of CAR-NK

Therapy for multiple myeloma (MM)

Treatment:
CAR-NK Treatment、
Research Unit:
Henan Province Cancer Hospital、
Patient Number:
13
Inclusion Criteria
Exclusion Criteria
Treatment Process
Potential Adverse Events
Partner
Partners
Galapagos

Galapagos is a comprehensive biopharmaceutical company with R&D, production and sales capabilities, dedicated to the discovery, development and commercialization of innovative drugs.

Xianbo Biology

Xianbo Biological is committed to bringing innovative cell therapy products to cancer patients.

Dr. Reddy’s

Dr. Reddy’s Laboratories established in 1984, headquatered in Hyderābād State.

01
-
Galapagos
Xianbo Biology
Dr. Reddy’s
News
News
15
2021.06

On June 15, the Shenzhen Municipal Bureau of Industry and Information Technology announced the list of "professional, 
proficient, special...

09
2021.05

BEIJING, May 13, 2021 /PRNewswire/ -- Beijing Time May 10, 2021 — Dr. Reddy's Laboratories Ltd. (BSE: 500124, 
NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) and...

17
2020.03

Shenzhen Pregene Obtained the Clinical Implied License for the Anti-BCMA CAR-T Drug from NMPA with 
the Support from Lewwin...

05
2020.03

On March 5, 2020, the Department of Science and Technology of Guangdong Province issued the Notice of the Department of 
Science and Technology of Guangdong Province on Identifying the Engineering...

Contact
Contact Us
Address
Address: 1B-605, Shenzhen Biomedicine Innovations Industrial Park, 14 Jinhui Road, Pingshan District, Shenzhen, Guangdong, China
Telephone